Assura PLC’s (AGR) “Hold” Rating Reaffirmed at Liberum Capital
Assura PLC (LON:AGR)‘s stock had its “hold” rating reissued by equities research analysts at Liberum Capital in a research report issued on Monday. They presently have a GBX 60 ($0.75) target price on the real estate investment trust’s stock. Liberum Capital’s target price would indicate a potential upside of 0.84% from the company’s current price.
Separately, Peel Hunt restated a “hold” rating and issued a GBX 55 ($0.69) target price on shares of Assura PLC in a research report on Tuesday, November 22nd.
Assura PLC (LON:AGR) opened at 59.4435 on Monday. Assura PLC has a 12-month low of GBX 48.08 and a 12-month high of GBX 61.00. The company’s 50-day moving average price is GBX 58.93 and its 200-day moving average price is GBX 57.68. The stock’s market cap is GBX 972.76 million.
About Assura PLC
Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.
Receive News & Stock Ratings for Assura PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura PLC and related stocks with our FREE daily email newsletter.